241 related articles for article (PubMed ID: 27760762)
1. Endothelin-1-Rho kinase interactions impair lung structure and cause pulmonary hypertension after bleomycin exposure in neonatal rat pups.
Gien J; Tseng N; Seedorf G; Kuhn K; Abman SH
Am J Physiol Lung Cell Mol Physiol; 2016 Dec; 311(6):L1090-L1100. PubMed ID: 27760762
[TBL] [Abstract][Full Text] [Related]
2. Long-term treatment with fasudil improves bleomycin-induced pulmonary fibrosis and pulmonary hypertension via inhibition of Smad2/3 phosphorylation.
Bei Y; Hua-Huy T; Duong-Quy S; Nguyen VH; Chen W; Nicco C; Batteux F; Dinh-Xuan AT
Pulm Pharmacol Ther; 2013 Dec; 26(6):635-43. PubMed ID: 23928001
[TBL] [Abstract][Full Text] [Related]
3. Inhaled nitric oxide improves lung structure and pulmonary hypertension in a model of bleomycin-induced bronchopulmonary dysplasia in neonatal rats.
Tourneux P; Markham N; Seedorf G; Balasubramaniam V; Abman SH
Am J Physiol Lung Cell Mol Physiol; 2009 Dec; 297(6):L1103-11. PubMed ID: 19837849
[TBL] [Abstract][Full Text] [Related]
4. Rho-kinase inhibitor prevents bleomycin-induced injury in neonatal rats independent of effects on lung inflammation.
Lee AH; Dhaliwal R; Kantores C; Ivanovska J; Gosal K; McNamara PJ; Letarte M; Jankov RP
Am J Respir Cell Mol Biol; 2014 Jan; 50(1):61-73. PubMed ID: 23947621
[TBL] [Abstract][Full Text] [Related]
5. Endothelial nitric oxide synthase-enhancing G-protein coupled receptor antagonist inhibits pulmonary artery hypertension by endothelin-1-dependent and endothelin-1-independent pathways in a monocrotaline model.
Liu CP; Dai ZK; Huang CH; Yeh JL; Wu BN; Wu JR; Chen IJ
Kaohsiung J Med Sci; 2014 Jun; 30(6):267-78. PubMed ID: 24835346
[TBL] [Abstract][Full Text] [Related]
6. Rescue treatment with a Rho-kinase inhibitor normalizes right ventricular function and reverses remodeling in juvenile rats with chronic pulmonary hypertension.
Xu EZ; Kantores C; Ivanovska J; Engelberts D; Kavanagh BP; McNamara PJ; Jankov RP
Am J Physiol Heart Circ Physiol; 2010 Dec; 299(6):H1854-64. PubMed ID: 20889845
[TBL] [Abstract][Full Text] [Related]
7. Effects of rho-kinase inhibition on pulmonary hypertension, lung growth, and structure in neonatal rats chronically exposed to hypoxia.
Ziino AJ; Ivanovska J; Belcastro R; Kantores C; Xu EZ; Lau M; McNamara PJ; Tanswell AK; Jankov RP
Pediatr Res; 2010 Feb; 67(2):177-82. PubMed ID: 19858775
[TBL] [Abstract][Full Text] [Related]
8. Differential roles of endothelin-1 ETA and ETB receptors and vasoactive intestinal polypeptide in regulation of the airways and the pulmonary vasculature in isolated rat lung.
Janosi T; Peták F; Fontao F; Morel DR; Beghetti M; Habre W
Exp Physiol; 2008 Nov; 93(11):1210-9. PubMed ID: 18567602
[TBL] [Abstract][Full Text] [Related]
9. Rho kinase mediates right ventricular systolic dysfunction in rats with chronic neonatal pulmonary hypertension.
Gosal K; Dunlop K; Dhaliwal R; Ivanovska J; Kantores C; Desjardins JF; Connelly KA; McNamara PJ; Jain A; Jankov RP
Am J Respir Cell Mol Biol; 2015 Jun; 52(6):717-27. PubMed ID: 25337652
[TBL] [Abstract][Full Text] [Related]
10. Acute vasodilator effects of Rho-kinase inhibitors in neonatal rats with pulmonary hypertension unresponsive to nitric oxide.
McNamara PJ; Murthy P; Kantores C; Teixeira L; Engelberts D; van Vliet T; Kavanagh BP; Jankov RP
Am J Physiol Lung Cell Mol Physiol; 2008 Feb; 294(2):L205-13. PubMed ID: 18032699
[TBL] [Abstract][Full Text] [Related]
11. Lack of EC-SOD worsens alveolar and vascular development in a neonatal mouse model of bleomycin-induced bronchopulmonary dysplasia and pulmonary hypertension.
Delaney C; Wright RH; Tang JR; Woods C; Villegas L; Sherlock L; Savani RC; Abman SH; Nozik-Grayck E
Pediatr Res; 2015 Dec; 78(6):634-40. PubMed ID: 26322414
[TBL] [Abstract][Full Text] [Related]
12. Fasudil reduces monocrotaline-induced pulmonary arterial hypertension: comparison with bosentan and sildenafil.
Mouchaers KT; Schalij I; de Boer MA; Postmus PE; van Hinsbergh VW; van Nieuw Amerongen GP; Vonk Noordegraaf A; van der Laarse WJ
Eur Respir J; 2010 Oct; 36(4):800-7. PubMed ID: 20351034
[TBL] [Abstract][Full Text] [Related]
13. Endothelin-1 impairs angiogenesis in vitro through Rho-kinase activation after chronic intrauterine pulmonary hypertension in fetal sheep.
Gien J; Tseng N; Seedorf G; Roe G; Abman SH
Pediatr Res; 2013 Mar; 73(3):252-62. PubMed ID: 23202724
[TBL] [Abstract][Full Text] [Related]
14. Rho-kinase inhibition alleviates pulmonary hypertension in transgenic mice expressing a dominant-negative type II bone morphogenetic protein receptor gene.
Yasuda T; Tada Y; Tanabe N; Tatsumi K; West J
Am J Physiol Lung Cell Mol Physiol; 2011 Nov; 301(5):L667-74. PubMed ID: 21856816
[TBL] [Abstract][Full Text] [Related]
15. [Fasudil reverses monocrotaline-induced pulmonary hypertension in rats].
Jiang H; Guan RJ; Wang HY
Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Mar; 41(3):239-44. PubMed ID: 23879951
[TBL] [Abstract][Full Text] [Related]
16. Endothelin-1 is elevated in monocrotaline pulmonary hypertension.
Frasch HF; Marshall C; Marshall BE
Am J Physiol; 1999 Feb; 276(2):L304-10. PubMed ID: 9950893
[TBL] [Abstract][Full Text] [Related]
17. Nonspecific endothelin-receptor antagonist blunts monocrotaline-induced pulmonary hypertension in rats.
Hill NS; Warburton RR; Pietras L; Klinger JR
J Appl Physiol (1985); 1997 Oct; 83(4):1209-15. PubMed ID: 9338430
[TBL] [Abstract][Full Text] [Related]
18. Fasudil preserves lung endothelial function and reduces pulmonary vascular remodeling in a rat model of end‑stage pulmonary hypertension with left heart disease.
Zhuang R; Wu J; Lin F; Han L; Liang X; Meng Q; Jiang Y; Wang Z; Yue A; Gu Y; Fan H; Zhou X; Liu Z
Int J Mol Med; 2018 Sep; 42(3):1341-1352. PubMed ID: 29901088
[TBL] [Abstract][Full Text] [Related]
19. Attenuation of pulmonary hypertension secondary to left ventricular dysfunction in the rat by Rho-kinase inhibitor fasudil.
Dai ZK; Wu BN; Chen IC; Chai CY; Wu JR; Chou SH; Yeh JL; Chen IJ; Tan MS
Pediatr Pulmonol; 2011 Jan; 46(1):45-59. PubMed ID: 20717937
[TBL] [Abstract][Full Text] [Related]
20. Maxingxiongting mixture attenuates hypoxia pulmonary arterial hypertension to improve right ventricular hypertrophy by inhibiting the rho-kinase signaling pathway.
An X; Li S; Weng X; Wang X; Wu H; Zhang X; Gao J; Yang R; Peng B; Li S; Weng X; Wang X; Zhang X; Gao J
J Tradit Chin Med; 2020 Dec; 40(6):992-998. PubMed ID: 33258351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
